DAPT 'Too Strong' After CABG for Heart Attacks, Trial Says

(Medage today) – Madrid – Double antiplatelet therapy (DAPT) has not improved the results after the coronary arteries’ pontage transplant (CABG) for acute coronary syndrome (ACS) but increased the risks, showed the Tacsi randomized trial. With Ticagrelor …